Phase III, Randomized, Double Blind Trial Low Dose Tamoxifen Versus Placebo in Hormone Replacement Therapy (HRT) Users (HOT)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2011 by European Institute of Oncology.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
European Institute of Oncology
ClinicalTrials.gov Identifier:
NCT01579734
First received: January 24, 2012
Last updated: April 17, 2012
Last verified: December 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2012
  Estimated Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)